1-20 of 82
Yi Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6147: Immune population changes in mammary adipose tissue during the development of obesity and their influence on triple negative breast cancer progression

Shimeng Liu, Yi Zhang, Myles Brown
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6147.
DOI: https://doi.org/10.1158/1538-7445.AM2022-6147
Published: 15 June 2022
View article
Journal Articles

Abstract 421: PLX-3618, a potent, selective monovalent BRD4 degrader demonstrates activity in models of prostate cancer

Kenneth Steadman, Gregory S. Parker, Geoffray Leriche, Sarah Fish, Julia Toth, Mary E. Spalding, Elizabeth Daniele, Aleksandar Jamborcic, Xiaoming Li, E Adam Kallel, Farhana Barmare, Kenneth Chng, Erika Green, Michael Hocker, Elliot Imler, Yi Zhang, Peggy A. Thompson, Simon Bailey
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 421.
DOI: https://doi.org/10.1158/1538-7445.AM2022-421
Published: 15 June 2022
View article
Journal Articles

Abstract 4221: Characterization of OVA-expressing immunogenic syngeneic tumor models for immune checkpoint inhibitor evaluation

Chenpan Nie, Yi Zhang, Jia Zheng, Annie X. An, Jun Zhou, Henry Q.X. Li, Jingjing Wang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 4221.
DOI: https://doi.org/10.1158/1538-7445.AM2022-4221
Published: 15 June 2022
View article
Journal Articles

Abstract 5499: Efficacy of icotinib as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE)

Kun Qian, Bin Hu, Ming He, Zi-Tong Wang, Yu Liu, Hua-Gang Liang, Zhi-Yong Su, Yu-Shang Cui, Li-Jun Liu, Yi Zhang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5499.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5499
Published: 15 June 2022
View article
Journal Articles

Abstract P5-13-31: Pik3ca mutations and myc amplification are associated with pathological complete response in human epidermal growth factor receptor 2-positive breast cancer patients receiving pyrotinib combined with trastuzumab neoadjuvant treatment

Qiyun Shi, Juncheng Xuhong, Jia Ge, Feng Liu, Yang Lan, Yi Zhang, Luo Tao, Xiuwu BIan, Xiaowei Qi, Jun Jiang
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-31.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P5-13-31
Published: 15 February 2022
View article
Journal Articles

Abstract PD15-04: Breast Cancer Index and assessment of the Net Treatment Benefit (NTB) of extended endocrine therapy in HR+ breast cancer

Marc Buyse, Jenna Wong, Samuel Salvaggio, Jean-Christophe Chiem, Yi Zhang, Kai Treuner, Elma Meershoek-Klein Kranenbarg, Mickaël De Backer, Gerrit-Jan Liefers, Catherine A Schnabel
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD15-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD15-04
Published: 15 February 2022
View article
Journal Articles

Abstract PD9-09: Breast cancer index and assessment of tumor proliferation by molecular grade index (MGI) within distinct HOXB13/IL17BR (H/I) subsets

Reshma Mahtani, Yuan Yuan, Kari B Wisinski, Jay Morris, Max Salganik, Yi Zhang, Catherine A Schnabel, Vk Gadi
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD9-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD9-09
Published: 15 February 2022
View article
Journal Articles

Abstract 65: Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade

Shengqing Gu, Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Ziyi Li, Clifford Meyer, Blair Stewig, Yingtian Xie, Xia Bu, Michael Manos, Alba Font-Tello, Evisa Gjini, Ana Lako, Klothilda Lim, Jake Conway, Alok Tewari, Zexian Zeng, Avinash Das Sahu, Collin Tokheim, Jason L. Weirather, Jingxin Fu, Yi Zhang, Benjamin Kroger, Jin Hua Liang, Paloma Cejas, Gordon J. Freeman, Scott J. Rodig, Henry Long, Benjamin E. Gewurz, F. Stephen Hodi, Myles Brown, X. Shirley Liu
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 65.
DOI: https://doi.org/10.1158/1538-7445.AM2021-65
Published: 01 July 2021
View article
Journal Articles

Abstract 1451: AN3025: A novel anti-human TNFR2 antibody that exhibits immune activation and strong anti-tumor activity in vivo

Yonglin Chen, Manxue Jia, Sherry Xu, Yanhui Zhao, Eric Chan, Meng Zhang, Emma Chen, Yi Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1451.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1451
Published: 01 July 2021
View article
Journal Articles

Abstract 1519: PD1 TurboCAR™ T cells: PD1-resistant CAR T cells with programmable cytokine signaling outputs

Regina Lin, Yi Zhang, Surabhi Srinivasan, Cecilia Lay, Shanshan Lang, Janette Sutton, Candice Manion, Tom Van Blarcom, Barbra Sasu, Siler Panowski
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1519.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1519
Published: 01 July 2021
View article
Journal Articles

Abstract 1505: Reprogramming cancer into antigen presenting cells as a novel immunotherapy

Miles H. Linde, Sarah F. Gurev, Paul Phan, Feifei Zhao, Eric J. Gars, Melissa Stafford, Thomas Köhnke, Payton L. Marshall, Amy C. Fan, Christopher G. Dove, Ian L. Linde, Lindsay P. Miller, Robbie G. Majzner, Tian Yi Zhang, Ravindra Majeti
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1505.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1505
Published: 01 July 2021
View article
Journal Articles

Abstract PS10-39: Risk factors for all-cause death and breast cancer-specific death in patients with HER2-positive and lymph node negative breast cancer : A retrospective analysis based on SEER database (2010 to 2017)

Ju Wang, Yi Zhang, Jun Jiang, Xiaowei Qi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS10-39.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS10-39
Published: 15 February 2021
View article
Journal Articles

Abstract PD2-11: Breast cancer index is a molecular signature of endocrine responsiveness that determines extended endocrine benefit independent of prognostic risk

Gerrit-Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Cornelis JH Van De Velde, Catherine A Schnabel
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD2-11.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD2-11
Published: 15 February 2021
View article
Journal Articles

Abstract GS4-09: Correlative studies of the breast cancer index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine benefit: A trans-aTTom study

Dennis C Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J Taylor, Elena F Brachtel, Sarah Pirrie, Catherine A Schnabel, Daniel W Rea, John MS Bartlett
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS4-09.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-GS4-09
Published: 15 February 2021
View article
Journal Articles

Abstract PO-092: Immune profiling of the tumor microenvironment using multiplexed ion beam imaging (MIBI)

Jason Ptacek, Srimoyee Ghosh, Lourdes Pablo, Bin Feng, Hailei Zhang, Yari Sigal, Jay G. Tarolli, Murat Aksoy, Yi Zhang, Rachel Finck, Jessica Finn
Journal: Cancer Research
Cancer Res (2020) 80 (21_Supplement): PO-092.
DOI: https://doi.org/10.1158/1538-7445.TUMHET2020-PO-092
Published: 03 November 2020
View article
Journal Articles

Abstract 6599: Screening and characterization of AlloCAR T targeting DLL3 for the treatment of small cell lung cancer

Yi Zhang, Silvia Tacheva-Grigorova, Zea Melton, Bryan Smith, Tao Sai, Tom Van Blarcom, Rafael Amado, Barbra Sasu, Siler Panowski
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6599.
DOI: https://doi.org/10.1158/1538-7445.AM2020-6599
Published: 15 August 2020
View article
Journal Articles

Abstract CT144: PD-1-CD28-enhanced receptor and anti-CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors

Xinfeng Chen, Xuan Zhao, Liping Wang, Weiyue Gu, Yi Zhang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT144.
DOI: https://doi.org/10.1158/1538-7445.AM2020-CT144
Published: 15 August 2020
View article
Journal Articles

Abstract 3239: SMIC CAR T cells: CAR T with temporally-controlled, programmable cytokine signaling outputs

Regina Lin, Andrew Nager, Spencer Park, Janette Sutton, Zea Melton, Yi Zhang, Bijan Boldajipour, Tom Van Blarcom, Siler Panowski, Javier Chaparro-Riggers, Barbra Sasu
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3239.
DOI: https://doi.org/10.1158/1538-7445.AM2020-3239
Published: 15 August 2020
View article
Journal Articles

Abstract P5-01-18: A non-invasive diagnostic assay of early stage breast cancer

Wanyan Tang, Xin Zhou, Haiwei Zhang, Chuang Ge, Huiqing Yu, Weiqi Nian, Yi Zhang
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-01-18.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-01-18
Published: 15 February 2020
View article
Journal Articles

Abstract P2-11-02: Breast Cancer Index predicts benefit from extended endocrine therapy in HR+ breast cancer

John Bartlett, Dennis Sgori, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Shalunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Elena Brachtel, Sarah Pirrie, Catherine Schnabel, Daniel Rea
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-11-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P2-11-02
Published: 15 February 2020
View article